List of Excipients in API acamprosate calcium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing acamprosate calcium
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Carilion Materials Management | CAMPRAL | acamprosate calcium | 68151-4760 | CELLULOSE, MICROCRYSTALLINE | |
Carilion Materials Management | CAMPRAL | acamprosate calcium | 68151-4760 | CROSPOVIDONE | |
Carilion Materials Management | CAMPRAL | acamprosate calcium | 68151-4760 | MAGNESIUM SILICATE | |
Carilion Materials Management | CAMPRAL | acamprosate calcium | 68151-4760 | MAGNESIUM STEARATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing acamprosate calcium
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 | CELLULOSE, MICROCRYSTALLINE |
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 | CROSPOVIDONE |
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 | HYPROMELLOSE 2910 |
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 | MAGNESIUM STEARATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for acamprosate calcium
Excipient focus: AMMONIA
acamprosate calcium drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | acamprosate calcium enteric-coated | 0378-6333 |
Mylan Institutional Inc | acamprosate calcium enteric-coated | 51079-241 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
acamprosate calcium drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
acamprosate calcium drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing CROSPOVIDONE
Excipient focus: FERROSOFERRIC OXIDE
acamprosate calcium drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | acamprosate calcium enteric-coated | 0378-6333 |
Mylan Institutional Inc | acamprosate calcium enteric-coated | 51079-241 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL DIBEHENATE
acamprosate calcium drug variants containing GLYCERYL DIBEHENATE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | acamprosate calcium enteric-coated | 0378-6333 |
Mylan Institutional Inc | acamprosate calcium enteric-coated | 51079-241 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing GLYCERYL DIBEHENATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
acamprosate calcium drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | acamprosate calcium enteric-coated | 0378-6333 |
Mylan Institutional Inc | acamprosate calcium enteric-coated | 51079-241 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
acamprosate calcium drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
American Health Packaging | acamprosate calcium | 60687-121 |
Carilion Materials Management | acamprosate calcium | 68151-4760 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM SILICATE
acamprosate calcium drug variants containing MAGNESIUM SILICATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
American Health Packaging | acamprosate calcium | 60687-121 |
Carilion Materials Management | acamprosate calcium | 68151-4760 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing MAGNESIUM SILICATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
AvKARE | acamprosate calcium | 42291-104 |
Zydus Pharmaceuticals (USA) Inc | acamprosate calcium | 68382-569 |
Zydus Lifesciences Limited | acamprosate calcium | 70771-1057 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
acamprosate calcium drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM TRISILICATE
acamprosate calcium drug variants containing MAGNESIUM TRISILICATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing MAGNESIUM TRISILICATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
American Health Packaging | acamprosate calcium | 60687-121 |
Carilion Materials Management | acamprosate calcium | 68151-4760 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID
acamprosate calcium drug variants containing METHACRYLIC ACID
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | acamprosate calcium | 68382-569 |
Zydus Lifesciences Limited | acamprosate calcium | 70771-1057 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing METHACRYLIC ACID
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
acamprosate calcium drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
American Health Packaging | acamprosate calcium | 60687-121 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Zydus Pharmaceuticals (USA) Inc | acamprosate calcium | 68382-569 |
Glenmark Pharmaceuticals Inc USA | acamprosate calcium | 68462-435 |
Zydus Lifesciences Limited | acamprosate calcium | 70771-1057 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
acamprosate calcium drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | acamprosate calcium enteric-coated | 0378-6333 |
Mylan Institutional Inc | acamprosate calcium enteric-coated | 51079-241 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
acamprosate calcium drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Glenmark Pharmaceuticals Inc USA | acamprosate calcium | 68462-435 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
American Health Packaging | acamprosate calcium | 60687-121 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
acamprosate calcium drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
American Health Packaging | acamprosate calcium | 60687-121 |
Carilion Materials Management | acamprosate calcium | 68151-4760 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
acamprosate calcium drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
AvKARE | acamprosate calcium | 42291-104 |
Zydus Pharmaceuticals (USA) Inc | acamprosate calcium | 68382-569 |
Zydus Lifesciences Limited | acamprosate calcium | 70771-1057 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
American Health Packaging | acamprosate calcium | 60687-121 |
Carilion Materials Management | acamprosate calcium | 68151-4760 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
acamprosate calcium drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
American Health Packaging | acamprosate calcium | 60687-121 |
Glenmark Pharmaceuticals Inc USA | acamprosate calcium | 68462-435 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
Carilion Materials Management | acamprosate calcium | 68151-4760 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
acamprosate calcium drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
AvKARE | acamprosate calcium | 42291-104 |
American Health Packaging | acamprosate calcium | 60687-121 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
acamprosate calcium drug variants containing POVIDONE K90
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | acamprosate calcium | 68382-569 |
Zydus Lifesciences Limited | acamprosate calcium | 70771-1057 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing POVIDONE K90
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
acamprosate calcium drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | acamprosate calcium | 68382-569 |
Zydus Lifesciences Limited | acamprosate calcium | 70771-1057 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
acamprosate calcium drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | acamprosate calcium enteric-coated | 0378-6333 |
Mylan Institutional Inc | acamprosate calcium enteric-coated | 51079-241 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
acamprosate calcium drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
acamprosate calcium drug variants containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | acamprosate calcium | 68382-569 |
Zydus Lifesciences Limited | acamprosate calcium | 70771-1057 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
acamprosate calcium drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals (USA) Inc | acamprosate calcium | 68382-569 |
Zydus Lifesciences Limited | acamprosate calcium | 70771-1057 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
acamprosate calcium drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | acamprosate calcium enteric-coated | 0378-6333 |
Mylan Institutional Inc | acamprosate calcium enteric-coated | 51079-241 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
acamprosate calcium drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | acamprosate calcium | 0093-5352 |
Major Pharmaceuticals | acamprosate calcium | 0904-7213 |
Marlex Pharmaceuticals Inc | acamprosate calcium | 10135-636 |
AvKARE | acamprosate calcium | 42291-104 |
>Company | >Ingredient | >NDC |
acamprosate calcium drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.